Eucrates Biomedical Acquisition Corp.

EUCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.04

$0 (0.00%)

At close: Apr 26, 2023, 03:14 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $42.23M

Enterprise Value $29.92M

Beta -0.07

Average Volume N/A

Shares Outstanding (Diluted) 2.98M

Shares Change YoY -77.87%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -1.1%

1Y CAGR (ann.) 1.6%

5Y CAGR (ann.) N/A

All-Time CAGR 0.2%

Valuation

PE Ratio 18.25

Forward PE N/A

PEG Ratio -0.13

Forward PEG -0.13

PS Ratio N/A

Forward PS N/A

PB Ratio 4.95

P/FCF Ratio -67.00

P/Adj. FCF Ratio -67.00

P/OCF Ratio -47.81

EV/Sales N/A

EV/EBIT -49.62

EV/EBITDA -11.62

EV/FCF -47.47

Earnings Yield 5.5%

FCF Yield -1.5%

Adj. FCF Yield -1.5%

Financial Health

Net Cash $12.37M

Total Debt $60.06K

Cash & Short-Term Investments $18.87K

Total Assets $12.49M

Current Ratio 2.03

Quick Ratio 2.03

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.10

OCF / Debt -10.49

Interest Coverage 0.00

Altman Z-Score 5.85

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 44.4%

Return on Equity 10.3%

Return on Invested Capital -5.6%

Return on Capital Employed -5.6%

Return on Tangible Assets 44.4%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Dec 30, 2022

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $5.96

Graham Upside -40.6%

Lynch Fair Value N/A

Lynch Upside N/A

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-630.29K

Free Cash Flow $-630.29K

Adj. Free Cash Flow $-630.29K

FCF Per Share -$0.21

OCF Per Share -$0.21

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-698K

EBITDA $-2.58M

Net Income $5.44M

EPS (Diluted) $0.55

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A